0 references
Use of Immune Globulin Manufactured from a Blended Plasma Pool of High-Titer RSV and Normal Source Plasma in an Adult with Severe ARDS COVID-19: Case Report
SSRN Electronic Journal2022
Related Papers
- → Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study(2018)78 cited
- → COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study(2020)9 cited
- [Ventilatory strategy for ARDS].(2016)
- → The clinical value of Angiopoietin 2 in prediction of the onset of acute respiratory distress syndrome(2014)
- → Ventilation management in COVID–19 ARDS vs ARDS from another origin(2021)